{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pregabalin-Lyrica", "query": { "intervention": "Pregabalin-Lyrica" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 175, "total_pages": 18, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pregabalin-Lyrica&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-26T00:44:53.872Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00954187", "title": "Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loma Linda University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 8, "start_date": "2009-11", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2017-01-09", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 1, "location_summary": "Loma Linda, California", "locations": [ { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00954187" }, { "nct_id": "NCT05053126", "title": "Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Abuse Potential" ], "interventions": [ { "name": "Pregabalin 300mg", "type": "DRUG" }, { "name": "pregabalin 450 mg", "type": "DRUG" }, { "name": "Pregabalin 300 mg with oxycodone 20 mg", "type": "DRUG" }, { "name": "pregabalin 450 mg with oxycodone 20 mg", "type": "DRUG" }, { "name": "oxycodone 20 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Specialty LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 60, "start_date": "2021-07-27", "completion_date": "2022-04-01", "has_results": true, "last_update_posted_date": "2023-08-14", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 1, "location_summary": "Marlton, New Jersey", "locations": [ { "city": "Marlton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05053126" }, { "nct_id": "NCT00141388", "title": "To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seizure Disorder, Partial" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 455, "start_date": "1998-07", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2009-11-06", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00141388" }, { "nct_id": "NCT00151528", "title": "An Open-Label Trial of Pregabalin in Patients With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 428, "start_date": "2005-01", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2021-01-22", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 93, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 78 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00151528" }, { "nct_id": "NCT00381095", "title": "A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bone Neoplasms", "Pain, Intractable", "Cancer" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 152, "start_date": "2006-12", "completion_date": "2010-10", "has_results": true, "last_update_posted_date": "2021-01-20", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 8, "location_summary": "Celebration, Florida • Kissimmee, Florida • Pensacola, Florida + 4 more", "locations": [ { "city": "Celebration", "state": "Florida" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00381095" }, { "nct_id": "NCT01555073", "title": "Preemptive Analgesia Following Uterine Artery Embolization", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Uterine Fibroids", "Uterine Artery Embolization" ], "interventions": [ { "name": "pregabalin/celecoxib", "type": "DRUG" }, { "name": "pregabalin/placebo", "type": "DRUG" }, { "name": "celecoxib/placebo", "type": "DRUG" }, { "name": "Placebo group", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 23, "start_date": "2011-10", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2016-07-28", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01555073" }, { "nct_id": "NCT02670161", "title": "Quality Improvement and Practice Based Research in Neurology Using the EMR", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Brain Tumors", "Epilepsy", "Migraine", "Mild Cognitive Impairment", "Concussion", "Multiple Sclerosis", "Neuropathy", "Parkinson's", "Restless Legs Syndrome", "Stroke" ], "interventions": [ { "name": "Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endeavor Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 3300, "start_date": "2016-05", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2025-08-24", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 1, "location_summary": "Evanston, Illinois", "locations": [ { "city": "Evanston", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02670161" }, { "nct_id": "NCT02187471", "title": "Treatment of Pain Associated With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain Associated With Fibromyalgia" ], "interventions": [ { "name": "DS-5565", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo tablet", "type": "DRUG" }, { "name": "Placebo capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1301, "start_date": "2015-01-16", "completion_date": "2017-01-12", "has_results": true, "last_update_posted_date": "2020-11-09", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 91, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 87 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02187471" }, { "nct_id": "NCT01345045", "title": "A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Neuropathic Pain" ], "interventions": [ { "name": "ABT-639", "type": "DRUG" }, { "name": "pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 193, "start_date": "2011-04", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2013-01-08", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 19, "location_summary": "Little Rock, Arkansas • Anaheim, California • Long Beach, California + 15 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01345045" }, { "nct_id": "NCT01271933", "title": "Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "pregabalin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 441, "start_date": "2011-03", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2021-01-22", "last_synced_at": "2026-09-26T00:44:53.872Z", "location_count": 30, "location_summary": "Orange, California • Santa Ana, California • Ocala, Florida + 27 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Ocala", "state": "Florida" }, { "city": "Pembroke Pines", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01271933" } ] }